Zimbabwe's health authorities on Thursday (19 February) began administering the long-acting injectable HIV prevention drug lenacapavir, making the country one of the first globally to roll it out as the southern African nation seeks to curb new infections. Health Minister Douglas Mombeshora said the programme, funded by the US and the Global Fund, would initially target more than 46,000 people at high risk of contracting HIV across 24 sites nationwide.
Zimbabwe's health authorities on Thursday (19 February) began administering the long-acting injectable HIV prevention drug lenacapavir, making the country one of the first globally to roll it out as the southern African nation seeks to curb new infections. Health Minister Douglas Mombeshora said the programme, funded by the US and the Global Fund, would initially target more than 46,000 people at high risk of contracting HIV across 24 sites nationwide.
